2014
DOI: 10.4067/s0034-98872014000100017
|View full text |Cite
|
Sign up to set email alerts
|

Evolución prolongada en síndrome de Crigler-Najjar tipo I

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 10 publications
0
1
0
1
Order By: Relevance
“…However, certain factors such as infections, fasting, or certain medications can trigger neurological complications in individuals with type II CNS [12][13][14][15]. Even though there are reported variations in the inheritance form of CNS, CNS is mostly autosomal recessive [15][16][17][18][19][20][21][22]. It is crucial to differentiate between CNS types I and II, as the treatment approaches differ.…”
Section: Discussionmentioning
confidence: 99%
“…However, certain factors such as infections, fasting, or certain medications can trigger neurological complications in individuals with type II CNS [12][13][14][15]. Even though there are reported variations in the inheritance form of CNS, CNS is mostly autosomal recessive [15][16][17][18][19][20][21][22]. It is crucial to differentiate between CNS types I and II, as the treatment approaches differ.…”
Section: Discussionmentioning
confidence: 99%
“…No obstante, el tratamiento de la hiperbilirrubinemia severa basado solo en el nivel de bilirrubina tiene un valor limitado para prevenir daño neurológico, porque existen otros factores biológicos, que estarían (32) implicados en la patogenia . Existen complicaciones clínicas que pueden incrementar la vulnerabilidad a la neurotoxicidad, como la sepsis neonatal, la deshidratación y la enfermedad hemolíticas, la hipoalbuminemia acidosis metabólica, la asfixia (33) perinatal y algunas enfermedades genéticas con trastornos del metabolismo de la bilirrubina como el Crigler Najer Tipo I y II (UGT1 y UGTII deficiencias de la uridil amino trasglutaminasa), la deficiencia de (34,35) la G6PD (Glucosa 6 fosfato deshidrogenasa) .…”
Section: El Neonato Con Ictericia Y El Riesgo De Encefalopatía Bilirrunclassified